The latest update is out from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ).
WuXi AppTec Co., Ltd. has released its first quarterly report for the financial year 2025, prepared in accordance with the PRC Accounting Standards and International Financial Reporting Standards. The report, which has not been audited, assures stakeholders of the truthfulness, accuracy, and completeness of its contents, as warranted by the company’s senior management. This announcement underscores the company’s commitment to transparency and accountability in its financial reporting, which is crucial for maintaining trust with investors and stakeholders.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company provides a range of services including contract development and manufacturing organization (CDMO) services, process development, formulation development, clinical trial medications, and production of active pharmaceutical ingredients.
YTD Price Performance: 1.42%
Average Trading Volume: 8,880,146
Technical Sentiment Signal: Buy
Current Market Cap: HK$171.2B
See more data about 2359 stock on TipRanks’ Stock Analysis page.